Scientists test 'Super Probiotic' cocktail to reset troubled guts
NCT ID NCT07238790
Summary
This early-stage study is testing the safety of a precisely defined mix of 157 live bacterial strains, called MITI-001, for people with irritable bowel syndrome where diarrhea is the main symptom (IBS-D). The treatment aims to restore a healthier balance of gut bacteria, which researchers believe drives symptoms in some patients. Participants will first take antibiotics to clear their current gut microbes, then receive the bacterial mix via endoscopy and take follow-up oral doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBS (IRRITABLE BOWEL SYNDROME) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford Digestive Health Clinic
Redwood City, California, 94063, United States
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.